Multipurpose prevention technology

Evofem Biosciences to Present at H.C. Wainwright BioConnect Conference

Retrieved on: 
Tuesday, January 4, 2022

SAN DIEGO, Jan. 4, 2022 /PRNewswire/ --Evofem Biosciences, Inc., (NASDAQ:EVFM) today announced that the Company will present and host one-on-one meetings at the H.C. Wainwright BioConnect Virtual Conference being held from January 10 13, 2022.

Key Points: 
  • SAN DIEGO, Jan. 4, 2022 /PRNewswire/ --Evofem Biosciences, Inc., (NASDAQ:EVFM) today announced that the Company will present and host one-on-one meetings at the H.C. Wainwright BioConnect Virtual Conference being held from January 10 13, 2022.
  • The Company's presentation will be available for on demand listening beginning at 7:00am ET on Monday, January 10, 2022 through the H.C. Wainwright BioConnect conference portal and via https://evofem.investorroom.com/HCWJan22 for 90 days.
  • To request a one-on-one meeting with Evofem during the conference, please contact your H.C. Wainwright representative or email [email protected] .
  • Phexxiis a registered trademark of Evofem Biosciences, Inc.